angiopoietin-like 4(English)

• a key mediator in a wide variety of biological processes. Decreased ANGPTL4 function is associated with a reduction of plasma triglycerides. Anti-ANGPTL4 therapies may help augment the treatment of cardiovascular disease
• LpL, MCP-1, MMP-9, mTOR, MYD88, NET, NF-κB, NLRP, NT-proBNP, PGC1-α, SAA, SGLT2, SIRT, Treg, T2DM, TGF, Th1, TLR, TNF, VCAM-1, VEGF, VLDL, VLDLR, AMPK, ATM, CCL, CCR2, CRP, CVD, DNase, EC, ECM, eNOS, FAP, FoxO1, GIP, GLP-1, HFpEF, HIF-1α, HRQL, ICAM-1, IFN, IL, iNOS, IRE1α, LDL, LDLR, LIFR
• Cardiology, Immunology, Metabolism, Molecular biology
• https://doi.org…acl.2018.01.012
• https://doi.org…LURE.125.012674